{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:57:37Z","timestamp":1791863857372,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["BMRC TCRP Grant (13\/1\/96\/19\/685)"],"award-info":[{"award-number":["BMRC TCRP Grant (13\/1\/96\/19\/685)"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is the fifth most common cancer with high mortality, due to late diagnosis and limited treatment options. Blood miRNAs, which circulate in a highly stable, cell-free form, show promise as novel potential biomarkers for early detection of HCC. Whole miRNome profiling was performed to identify deregulated miRNAs between HCC and normal healthy (NH) volunteers. These deregulated miRNAs were validated in an independent cohort of HCC, NH and chronic Hepatitis B (CHB) volunteers and finally in a 3<jats:sup>rd<\/jats:sup> cohort comprising NH, CHB, cirrhotic and HCC volunteers to evaluate miRNA changes during disease progression. The associations between circulating miRNAs and liver-damage markers, clinicopathological characteristics and survival outcomes were analysed to identify prognostic markers. Twelve miRNAs are differentially expressed between HCC and NH individuals in all three cohorts. Five upregulated miRNAs (miR-122-5p, miR-125b-5p, miR-885-5p, miR-100-5p and miR-148a-3p) in CHB, cirrhosis and HCC patients are potential biomarkers for CHB infection, while miR-34a-5p can be a biomarker for cirrhosis. Notably, four miRNAs (miR-1972, miR-193a-5p, miR-214-3p and miR-365a-3p) can distinguish HCC from other non-HCC individuals. Six miRNAs are potential prognostic markers for overall survival.<\/jats:p>","DOI":"10.1038\/s41598-019-46872-8","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:02:38Z","timestamp":1563444158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Yu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Shen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K. P.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Yip","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng Chung","family":"Cheow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0584-2584","authenticated-orcid":false,"given":"Pierce K. H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony K. H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B. B.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinesh Lee","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajneesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Pin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee Huang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y. F.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"London Lucien P. J.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P. E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6992-2319","authenticated-orcid":false,"given":"Chee Kiat","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline G. L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"46872_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/srep45846","volume":"7","author":"MC Wong","year":"2017","unstructured":"Wong, M. C. et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep 7, 45846, https:\/\/doi.org\/10.1038\/srep45846 (2017).","journal-title":"Sci Rep"},{"key":"46872_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/HMER.S16316","volume":"4","author":"R Dhanasekaran","year":"2012","unstructured":"Dhanasekaran, R., Limaye, A. & Cabrera, R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4, 19\u201337, https:\/\/doi.org\/10.2147\/HMER.S16316 (2012).","journal-title":"Hepat Med"},{"issue":"Suppl 4","key":"46872_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","volume":"15","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal, A. J., Yoon, S. K. & Lencioni, R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15(Suppl 4), 14\u201322, https:\/\/doi.org\/10.1634\/theoncologist.2010-S4-14 (2010).","journal-title":"Oncologist"},{"key":"46872_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/egh.09.35","volume":"3","author":"MI Shariff","year":"2009","unstructured":"Shariff, M. I. et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 3, 353\u2013367, https:\/\/doi.org\/10.1586\/egh.09.35 (2009).","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"46872_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","volume":"43","author":"AM Di Bisceglie","year":"2005","unstructured":"Di Bisceglie, A. M. et al. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol 43, 434\u2013441 (2005).","journal-title":"J Hepatol"},{"key":"46872_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857\u2013866, https:\/\/doi.org\/10.1038\/nrc1997 (2006).","journal-title":"Nat Rev Cancer"},{"key":"46872_CR7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","volume":"25","author":"Y Murakami","year":"2006","unstructured":"Murakami, Y. et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537\u20132545, https:\/\/doi.org\/10.1038\/sj.onc.1209283 (2006).","journal-title":"Oncogene"},{"key":"46872_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","volume":"81C","author":"N Yang","year":"2015","unstructured":"Yang, N., Ekanem, N. R., Sakyi, C. A. & Ray, S. D. Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev 81C, 62\u201374, https:\/\/doi.org\/10.1016\/j.addr.2014.10.029 (2015).","journal-title":"Adv Drug Deliv Rev"},{"key":"46872_CR9","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","volume":"67","author":"L Gramantieri","year":"2007","unstructured":"Gramantieri, L. et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67, 6092\u20136099, https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4607 (2007).","journal-title":"Cancer Res"},{"key":"46872_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/msb.2010.58","volume":"6","author":"J Burchard","year":"2010","unstructured":"Burchard, J. et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6, 402, https:\/\/doi.org\/10.1038\/msb.2010.58 (2010).","journal-title":"Mol Syst Biol"},{"key":"46872_CR11","doi-asserted-by":"publisher","first-page":"e15304","DOI":"10.1371\/journal.pone.0015304","volume":"6","author":"Y Mizuguchi","year":"2011","unstructured":"Mizuguchi, Y. et al. Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One 6, e15304, https:\/\/doi.org\/10.1371\/journal.pone.0015304 (2011).","journal-title":"PLoS One"},{"key":"46872_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1073\/pnas.0907904107","volume":"107","author":"P Pineau","year":"2010","unstructured":"Pineau, P. et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107, 264\u2013269, https:\/\/doi.org\/10.1073\/pnas.0907904107 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"46872_CR13","doi-asserted-by":"publisher","first-page":"13205","DOI":"10.1074\/jbc.M707629200","volume":"283","author":"Y Wang","year":"2008","unstructured":"Wang, Y. et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283, 13205\u201313215, https:\/\/doi.org\/10.1074\/jbc.M707629200 (2008).","journal-title":"J Biol Chem"},{"key":"46872_CR14","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513\u201310518, https:\/\/doi.org\/10.1073\/pnas.0804549105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"46872_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2014.09.001","volume":"81C","author":"G Cheng","year":"2015","unstructured":"Cheng, G. Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev 81C, 75\u201393, https:\/\/doi.org\/10.1016\/j.addr.2014.09.001 (2015).","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"46872_CR16","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s13277-014-2803-2","volume":"36","author":"Kailiu Wu","year":"2014","unstructured":"Wu, K., Li, L. & Li, S. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies. Tumour Biol, https:\/\/doi.org\/10.1007\/s13277-014-2803-2 (2014).","journal-title":"Tumor Biology"},{"key":"46872_CR17","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","volume":"29","author":"J Zhou","year":"2011","unstructured":"Zhou, J. et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29, 4781\u20134788, https:\/\/doi.org\/10.1200\/JCO.2011.38.2697 (2011).","journal-title":"J Clin Oncol"},{"key":"46872_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mc.20712","volume":"50","author":"J Xu","year":"2011","unstructured":"Xu, J. et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50, 136\u2013142, https:\/\/doi.org\/10.1002\/mc.20712 (2011).","journal-title":"Mol Carcinog"},{"key":"46872_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2011.01.111","volume":"406","author":"J Li","year":"2011","unstructured":"Li, J., Wang, Y., Yu, W., Chen, J. & Luo, J. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406, 70\u201373, https:\/\/doi.org\/10.1016\/j.bbrc.2011.01.111 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"46872_CR20","doi-asserted-by":"publisher","first-page":"e107986","DOI":"10.1371\/journal.pone.0107986","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan, Y. et al. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. PLoS One 9, e107986, https:\/\/doi.org\/10.1371\/journal.pone.0107986 (2014).","journal-title":"PLoS One"},{"key":"46872_CR21","doi-asserted-by":"publisher","first-page":"e28486","DOI":"10.1371\/journal.pone.0028486","volume":"6","author":"P Qi","year":"2011","unstructured":"Qi, P. et al. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 6, e28486, https:\/\/doi.org\/10.1371\/journal.pone.0028486 (2011).","journal-title":"PLoS One"},{"key":"46872_CR22","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1007\/s11033-014-3322-3","volume":"41","author":"BG Giray","year":"2014","unstructured":"Giray, B. G. et al. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Mol Biol Rep 41, 4513\u20134519, https:\/\/doi.org\/10.1007\/s11033-014-3322-3 (2014).","journal-title":"Mol Biol Rep"},{"issue":"2","key":"46872_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/CBM-140451","volume":"15","author":"Yajie Wang","year":"2015","unstructured":"Wang, Y. et al. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Cancer Biomark, https:\/\/doi.org\/10.3233\/CBM-140451 (2014).","journal-title":"Cancer Biomarkers"},{"key":"46872_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/jnci\/djk174","volume":"99","author":"S Benowitz","year":"2007","unstructured":"Benowitz, S. Liver cancer biomarkers struggling to succeed. Journal of the National Cancer Institute 99, 590\u2013591, https:\/\/doi.org\/10.1093\/jnci\/djk174 (2007).","journal-title":"Journal of the National Cancer Institute"},{"key":"46872_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.7150\/jca.21180","volume":"9","author":"O Rapado-Gonzalez","year":"2018","unstructured":"Rapado-Gonzalez, O. et al. Human salivary microRNAs in Cancer. J Cancer 9, 638\u2013649, https:\/\/doi.org\/10.7150\/jca.21180 (2018).","journal-title":"J Cancer"},{"key":"46872_CR26","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.7754\/Clin.Lab.2017.170607","volume":"63","author":"R Dumache","year":"2017","unstructured":"Dumache, R. Early Diagnosis of Oral Squamous Cell Carcinoma by Salivary microRNAs. Clin Lab 63, 1771\u20131776, https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170607 (2017).","journal-title":"Clin Lab"},{"key":"46872_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biocel.2014.05.020","volume":"53","author":"A Wojcicka","year":"2014","unstructured":"Wojcicka, A. et al. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. Int J Biochem Cell Biol 53, 208\u2013217, https:\/\/doi.org\/10.1016\/j.biocel.2014.05.020 (2014).","journal-title":"Int J Biochem Cell Biol"},{"key":"46872_CR28","first-page":"1705","volume":"8","author":"Z Chen","year":"2015","unstructured":"Chen, Z. et al. Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma. Int J Clin Exp Pathol 8, 1705\u20131711 (2015).","journal-title":"Int J Clin Exp Pathol"},{"key":"46872_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/CS20100297","volume":"120","author":"J Gui","year":"2011","unstructured":"Gui, J. et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 120, 183\u2013193, https:\/\/doi.org\/10.1042\/CS20100297 (2011).","journal-title":"Clin Sci (Lond)"},{"key":"46872_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.phrs.2018.06.019","volume":"134","author":"AED Amaral","year":"2018","unstructured":"Amaral, A. E. D. et al. MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival. Pharmacol Res 134, 179\u2013192, https:\/\/doi.org\/10.1016\/j.phrs.2018.06.019 (2018).","journal-title":"Pharmacol Res"},{"key":"46872_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/lt.22438","volume":"18","author":"WR Farid","year":"2012","unstructured":"Farid, W. R. et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 18, 290\u2013297, https:\/\/doi.org\/10.1002\/lt.22438 (2012).","journal-title":"Liver Transpl"},{"key":"46872_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2018.04.016","volume":"12","author":"K You","year":"2018","unstructured":"You, K. et al. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids 12, 57\u201366, https:\/\/doi.org\/10.1016\/j.omtn.2018.04.016 (2018).","journal-title":"Mol Ther Nucleic Acids"},{"key":"46872_CR33","doi-asserted-by":"publisher","first-page":"e35331","DOI":"10.1371\/journal.pone.0035331","volume":"7","author":"K Yuan","year":"2012","unstructured":"Yuan, K. et al. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 7, e35331, https:\/\/doi.org\/10.1371\/journal.pone.0035331 (2012).","journal-title":"PLoS One"},{"key":"46872_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau, C. et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87\u201398, https:\/\/doi.org\/10.1016\/j.cmet.2006.01.005 (2006).","journal-title":"Cell Metab"},{"key":"46872_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","volume":"142","author":"I Laudadio","year":"2012","unstructured":"Laudadio, I. et al. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology 142, 119\u2013129, https:\/\/doi.org\/10.1053\/j.gastro.2011.09.001 (2012).","journal-title":"Gastroenterology"},{"key":"46872_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbrc.2010.07.021","volume":"398","author":"L Qiu","year":"2010","unstructured":"Qiu, L. et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 398, 771\u2013777, https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.021 (2010).","journal-title":"Biochem Biophys Res Commun"},{"key":"46872_CR37","doi-asserted-by":"publisher","first-page":"75038","DOI":"10.18632\/oncotarget.12602","volume":"7","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt\/beta-catenin signaling pathway. Oncotarget 7, 75038\u201375051, https:\/\/doi.org\/10.18632\/oncotarget.12602 (2016).","journal-title":"Oncotarget"},{"key":"46872_CR38","doi-asserted-by":"publisher","first-page":"e44206","DOI":"10.1371\/journal.pone.0044206","volume":"7","author":"H Xia","year":"2012","unstructured":"Xia, H., Ooi, L. L. & Hui, K. M. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 7, e44206, https:\/\/doi.org\/10.1371\/journal.pone.0044206 (2012).","journal-title":"PLoS One"},{"key":"46872_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11010-013-1753-0","volume":"383","author":"P Chen","year":"2013","unstructured":"Chen, P., Zhao, X. & Ma, L. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 383, 49\u201358, https:\/\/doi.org\/10.1007\/s11010-013-1753-0 (2013).","journal-title":"Mol Cell Biochem"},{"key":"46872_CR40","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3892\/etm.2017.4244","volume":"13","author":"M Li","year":"2017","unstructured":"Li, M. et al. miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2. Exp Ther Med 13, 2279\u20132285, https:\/\/doi.org\/10.3892\/etm.2017.4244 (2017).","journal-title":"Exp Ther Med"},{"key":"46872_CR41","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.26355\/eurrev_201811_16257","volume":"22","author":"JT Wang","year":"2018","unstructured":"Wang, J. T. & Wang, Z. H. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 22, 7233\u20137239, https:\/\/doi.org\/10.26355\/eurrev_201811_16257 (2018).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"46872_CR42","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1111\/jcmm.14121","volume":"23","author":"P Li","year":"2019","unstructured":"Li, P., Xiao, Z., Luo, J., Zhang, Y. & Lin, L. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1. J Cell Mol Med 23, 2475\u20132488, https:\/\/doi.org\/10.1111\/jcmm.14121 (2019).","journal-title":"J Cell Mol Med"},{"key":"46872_CR43","doi-asserted-by":"publisher","first-page":"e7764","DOI":"10.1097\/MD.0000000000007764","volume":"96","author":"W Shi","year":"2017","unstructured":"Shi, W. et al. Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma. Medicine (Baltimore) 96, e7764, https:\/\/doi.org\/10.1097\/MD.0000000000007764 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"46872_CR44","first-page":"5576","volume":"9","author":"X Sun","year":"2017","unstructured":"Sun, X., Wang, M., Liu, H. & Wang, J. MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1. Am J Transl Res 9, 5576\u20135584 (2017).","journal-title":"Am J Transl Res"},{"key":"46872_CR45","doi-asserted-by":"publisher","first-page":"e109347","DOI":"10.1371\/journal.pone.0109347","volume":"9","author":"M Liu","year":"2014","unstructured":"Liu, M. et al. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. PLoS One 9, e109347, https:\/\/doi.org\/10.1371\/journal.pone.0109347 (2014).","journal-title":"PLoS One"},{"key":"46872_CR46","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1097\/MD.0000000000000602","volume":"94","author":"F Sonohara","year":"2015","unstructured":"Sonohara, F. et al. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases. Medicine (Baltimore) 94, e602, https:\/\/doi.org\/10.1097\/MD.0000000000000602 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"46872_CR47","first-page":"14830","volume":"8","author":"H Yao","year":"2015","unstructured":"Yao, H., Liu, X., Chen, S., Xia, W. & Chen, X. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma. Int J Clin Exp Pathol 8, 14830\u201314835 (2015).","journal-title":"Int J Clin Exp Pathol"},{"key":"46872_CR48","doi-asserted-by":"publisher","first-page":"27736","DOI":"10.18632\/oncotarget.4811","volume":"6","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. MicroRNA-424 inhibits Akt3\/E2F3 axis and tumor growth in hepatocellular carcinoma. Oncotarget 6, 27736\u201327750, https:\/\/doi.org\/10.18632\/oncotarget.4811 (2015).","journal-title":"Oncotarget"},{"key":"46872_CR49","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.febslet.2012.10.053","volume":"586","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. FEBS Lett 586, 4362\u20134370, https:\/\/doi.org\/10.1016\/j.febslet.2012.10.053 (2012).","journal-title":"FEBS Lett"},{"key":"46872_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14348\/molcells.2016.2161","volume":"39","author":"K Cao","year":"2016","unstructured":"Cao, K. et al. miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin. Mol Cells 39, 96\u2013102, https:\/\/doi.org\/10.14348\/molcells.2016.2161 (2016).","journal-title":"Mol Cells"},{"key":"46872_CR51","doi-asserted-by":"publisher","first-page":"e108708","DOI":"10.1371\/journal.pone.0108708","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct\/indirect mechanism. PLoS One 9, e108708, https:\/\/doi.org\/10.1371\/journal.pone.0108708 (2014).","journal-title":"PLoS One"},{"key":"46872_CR52","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3892\/or.2015.3936","volume":"33","author":"CY Huang","year":"2015","unstructured":"Huang, C. Y. et al. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncol Rep 33, 2889\u20132898, https:\/\/doi.org\/10.3892\/or.2015.3936 (2015).","journal-title":"Oncol Rep"},{"key":"46872_CR53","doi-asserted-by":"publisher","first-page":"14779","DOI":"10.1007\/s13277-016-5369-3","volume":"37","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis. Tumour Biol 37, 14779\u201314787, https:\/\/doi.org\/10.1007\/s13277-016-5369-3 (2016).","journal-title":"Tumour Biol"},{"key":"46872_CR54","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41388-017-0057-3","volume":"37","author":"S Hua","year":"2018","unstructured":"Hua, S. et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene 37, 1624\u20131636, https:\/\/doi.org\/10.1038\/s41388-017-0057-3 (2018).","journal-title":"Oncogene"},{"key":"46872_CR55","first-page":"120","volume":"8","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival. Am J Cancer Res 8, 120\u2013131 (2018).","journal-title":"Am J Cancer Res"},{"key":"46872_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach, H., Nishida, N., Calin, G. A. & Pantel, K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11, 145\u2013156, https:\/\/doi.org\/10.1038\/nrclinonc.2014.5 (2014).","journal-title":"Nat Rev Clin Oncol"},{"key":"46872_CR57","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/cam4.1390","volume":"7","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. Cancer Med 7, 1670\u20131679, https:\/\/doi.org\/10.1002\/cam4.1390 (2018).","journal-title":"Cancer Med"},{"key":"46872_CR58","unstructured":"Partek\u00ae Genomics Suite\u00ae v. Revision 6.6 (Partek Inc., St. Louis, 2018)."},{"key":"46872_CR59","unstructured":"R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2018)."},{"key":"46872_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77, https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","journal-title":"BMC Bioinformatics"},{"key":"46872_CR61","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing, T., Sander, O., Beerenwinkel, N. & Lengauer, T. ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940\u20133941, https:\/\/doi.org\/10.1093\/bioinformatics\/bti623 (2005).","journal-title":"Bioinformatics"},{"key":"46872_CR62","unstructured":"A Package for Survival Analysis in S (2015)."},{"key":"46872_CR63","doi-asserted-by":"crossref","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model. (Springer, 2000).","DOI":"10.1007\/978-1-4757-3294-8"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46872-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:43:51Z","timestamp":1671277431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46872-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46872"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46872-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"assertion":[{"value":"17 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10464"}}